Location: West Conshohocken, PA
CIK: 0001802528 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $772M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 2,048,647 | $88.97M | 11.5% | $22.03 | +72.7% | COM | 03770N101 |
| AXSM | AXSOME THERAPEUTICS INC | 815,176 | $85.1M | 11.0% | $49.79 | +112.7% | COM | 05464T104 |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,711,444 | $74.45M | 9.6% | $18.70 | +1.3% | COM | 29337E102 |
| SRRK | SCHOLAR ROCK HLDG CORP | 1,824,031 | $64.61M | 8.4% | $32.27 | -2.7% | COM | 80706P103 |
| SYRE | SPYRE THERAPEUTICS INC | 4,018,101 | $60.15M | 7.8% | $31.80 | -53.5% | COM NEW | 00773J202 |
| NUVL | NUVALENT INC | 727,563 | $55.51M | 7.2% | $22.67 | +222.8% | COM | 670703107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,707,191 | $50.43M | 6.5% | $15.37 | +22.1% | COM | 252828108 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 1,772,839 | $49.05M | 6.4% | $21.28 | +19.6% | ORD SHS CL A | G52694109 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,459,913 | $48.37M | 6.3% | $16.55 | -18.0% | COM | 92790C104 |
| COGT | COGENT BIOSCIENCES INC | 6,225,641 | $44.7M | 5.8% | $8.53 | -35.0% | COM | 19240Q201 |
| ORKA | ORUKA THERAPEUTICS INC | 3,371,922 | $37.8M | 4.9% | $34.30 | -69.6% | COM | 687604108 |
| JBIO | JADE BIOSCIENCES INC | 3,220,368 | $32.17M | 4.2% | $33.31 | 0.0% | COM NEW | 008064206 |
| CBIO | CRESCENT BIOPHARMA INC. | 1,387,866 | $22.4M | 2.9% | $21.15 | 0.0% | COM | G2545C104 |
| — | ASTRIA THERAPEUTICS INC | 3,554,129 | $19.05M | 2.5% | $9.99 | — | COM | 04635X102 |
| ZBIO | ZENAS BIOPHARMA INC | 1,892,806 | $18.34M | 2.4% | $17.98 | -45.8% | COM | 98937L105 |
| IKT | INHIBIKASE THERAPEUTICS INC | 6,125,000 | $11.94M | 1.5% | $2.49 | -21.5% | COM NEW | 45719W205 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,896,582 | $8.845M | 1.1% | $1.61 | 0.0% | COM | 23284F105 |